InHandPlus Inc., a pioneering medtech startup founded in 2019, has emerged as a frontrunner in the realm of healthcare innovation. With a mission to provide convenient and efficient healthcare solutions, InHandPlus has introduced groundbreaking technology Doctor on Wrist smartwatch. This innovative device integrates cutting-edge AI technology powered by ChatGPT, marking a significant advancement in personalized healthcare management.
InHandPlus’s Doctor on Wrist represents a fusion of advanced AI capabilities and wearable technology designed to empower users to manage their health proactively. This AI-powered smartwatch promises to transform healthcare delivery through its personalized approach to patient care. It offers tailored solutions for individuals managing chronic conditions, seniors, and those navigating mental health challenges.
Revolutionizing Patient Care with On-Device AI
The Doctor on Wrist ecosystem seamlessly integrates a mobile application, a web platform, and the AI-powered smartwatch. This trifecta enables automatic recording and management of medication, dietary information, and lifestyle data, fostering enhanced patient engagement and adherence to treatment regimens.
Key Features of Doctor on Wrist
- On-Device AI: Equipped with on-device AI capabilities, the Doctor on Wrist smartwatch offers real-time analysis and insights into medication adherence and health behaviors, ensuring proactive management of individual health journeys. Based on the camera mounted on the smartwatch band and the AI technology (on-device AI) mounted within the smartwatch, the user’s hand movements and objects held in the hand can be analyzed.
- Seamless Integration: The accompanying mobile app functions as an eDiary, synchronizing effortlessly with the smartwatch to automate the recording of medication and dietary data, empowering patients to take control of their health. Real-world data (medication, diet, health data, emergency data, etc.) analyzed in real time through a smartwatch can be shared with hospitals, medical institutions, and guardians and used for data-based remote patient management.
- Doctor on Wrist Interface: The user-friendly interface and medication alarm feature ensure compliance with prescribed treatments. At the same time, the device’s ability to analyze various health indicators enhances its utility in healthcare management. Medication, diet, and various health data analyzed by the smartwatch are linked to ChatGPT, and a personalized AI health coaching service is provided through voice conversation.
Endorsements and Accolades from the Healthcare Community
The smartwatch, recipient of consecutive CES Innovation Awards in 2022 and 2023, promises to transform healthcare delivery through its personalized approach to patient care.
Studies have demonstrated a 30% improvement in medication adherence among Doctor on Wrist smartwatch users, garnering endorsements from industry leaders such as Bayer and Merck. Peer-reviewed studies published in prestigious journals, including the World Allergy Organization Journal, have highlighted the efficacy of the InHandPlus smartwatch’s potential to improve patient’s medication adherence and outcomes across various healthcare needs significantly. Currently, the Inhand Plus solution is widely used in global pharmaceutical clinical trials and remote patient management.
InHandPlus’s Doctor on Wrist represents a paradigm shift in healthcare delivery, leveraging AI technology to deliver personalized, data-driven care to individuals worldwide. As digital health evolves, InHandPlus remains committed to setting new standards and empowering patients and healthcare providers.
Also Read,
- South Korea Launches CVC Alliance with 42 Corporations to Drive $6.2 Billion Innovation Boost for Startups
- Korean Startup J&T Biotech develops self-use auto-injector for allergy medication
- PMX aims to improve the disease screening and diagnosis with a breakthrough AI medical imaging solution
- Korean Startup ZEROONE.AI Revolutionizes Medical Decision-Making with Advanced AI Technology
- Korean healthcare startup AIRS Medical raises $20 million in Series B funding
Keep tab on latest news in the Korean startup ecosystem & follow us on LinkedIN, Facebook, and Twitter for more exciting updates and insights.
